María‐Carlota Londoño

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

David Roth, David R. Nelson, Annette Bruchfeld et al. · The Lancet · 2015 · 666 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients

Carlos Benítez, María‐Carlota Londoño, Rosa Miquel et al. · Hepatology · 2013 · 313 citations · Full text

Medicine, Immunology, Pharmacology +17

Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis

Sabela Lens, Edilmar Alvarado‐Tápias, Zoe Mariñó et al. · Gastroenterology · 2017 · 270 citations

Medicine, Pharmacology, Pharmacotherapy +12

Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation

Xavier Forns, Michael Charlton, Jill Denning et al. · Hepatology · 2014 · 229 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation

María‐Carlota Londoño, Andrés Cárdenas, Llorenç Quintó et al. · Gut · 2007 · 222 citations · Full text

Medicine, Internal Medicine, Surgery +17